Belgium
· Delayed Price · Currency is EUR Sequana Medical NV Statistics
Total Valuation
EBR:SEQUA has a market cap or net worth of EUR 54.45 million. The enterprise value is 90.76 million.
| Market Cap | 54.45M |
| Enterprise Value | 90.76M |
Important Dates
The next estimated earnings date is Friday, June 13, 2025.
| Earnings Date | Jun 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
EBR:SEQUA has 52.87 million shares outstanding. The number of shares has increased by 23.48% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 52.87M |
| Shares Change (YoY) | +23.48% |
| Shares Change (QoQ) | +14.56% |
| Owned by Insiders (%) | 11.59% |
| Owned by Institutions (%) | 21.99% |
| Float | 25.13M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 516.14 |
| PB Ratio | -1.23 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.03 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -4.46 |
Financial Position
The company has a current ratio of 0.12
| Current Ratio | 0.12 |
| Quick Ratio | 0.08 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.97 |
| Interest Coverage | -7.10 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -116.66% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 43.24% |
| Revenue Per Employee | 2,198 |
| Profits Per Employee | -930,284 |
| Employee Count | 62 |
| Asset Turnover | 0.01 |
| Inventory Turnover | 0.01 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -27.46% in the last 52 weeks. The beta is -0.02, so EBR:SEQUA's price volatility has been lower than the market average.
| Beta (5Y) | -0.02 |
| 52-Week Price Change | -27.46% |
| 50-Day Moving Average | 1.29 |
| 200-Day Moving Average | 1.29 |
| Relative Strength Index (RSI) | 45.86 |
| Average Volume (20 Days) | 234,189 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, EBR:SEQUA had revenue of EUR 105,500 and -44.65 million in losses. Loss per share was -1.22.
| Revenue | 105,500 |
| Gross Profit | 79,057 |
| Operating Income | -18.71M |
| Pretax Income | -44.37M |
| Net Income | -44.65M |
| EBITDA | -18.41M |
| EBIT | -18.71M |
| Loss Per Share | -1.22 |
Balance Sheet
The company has 3.81 million in cash and 40.11 million in debt, giving a net cash position of -36.30 million or -0.69 per share.
| Cash & Cash Equivalents | 3.81M |
| Total Debt | 40.11M |
| Net Cash | -36.30M |
| Net Cash Per Share | -0.69 |
| Equity (Book Value) | -44.38M |
| Book Value Per Share | -1.00 |
| Working Capital | -46.79M |
Cash Flow
In the last 12 months, operating cash flow was -20.26 million and capital expenditures -95,130, giving a free cash flow of -20.35 million.
| Operating Cash Flow | -20.26M |
| Capital Expenditures | -95,130 |
| Free Cash Flow | -20.35M |
| FCF Per Share | -0.38 |
Margins
| Gross Margin | 74.94% |
| Operating Margin | -17,731.38% |
| Pretax Margin | -42,059.94% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
EBR:SEQUA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -23.48% |
| Shareholder Yield | -23.48% |
| Earnings Yield | -82.00% |
| FCF Yield | -37.38% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
EBR:SEQUA has an Altman Z-Score of -46.55. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -46.55 |
| Piotroski F-Score | n/a |